Arpida

Closed

Arpida was founded in 1997, is headquartered in Reinach, Switzerland, lists 11–50 employees, and has $62.4M in recorded funding across 2 rounds.

Headquarters
Reinach
Employees
11–50
Founded
1997
Business Model
B2B
Website
arpida.com
Total Funding
$62.4M
Last Round
$39.4M Series COct 2005
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Arpida AG (SIX: ARPN) was a Swiss biopharmaceutical company headquartered in Reinach, near Basel, Switzerland, founded in 1997, focused on novel antibiotics to combat growing microbial resistance. Its lead product candidate was intravenous iclaprim, targeting severe infections including MRSA. After a Phase II pneumonia trial was halted in late 2008, the company cut roughly 75% of its workforce and restructured around its key asset. Arpida subsequently underwent a reverse merger and became Evolva Holding AG, ending its existence as an independent company.

Summary

Arpida is a Biotech company based in Reinach, Switzerland, founded in 1997. It lists 11–50 employees. It has raised $62.4M in total across 2 rounds, most recently a $39.4M Series C round in Oct 2005.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries COct 2005
$39.4M

Sign up to see all 2 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arpida on Indexed.vc
<a href="https://indexed.vc/companies/arpida"><img src="https://indexed.vc/api/badge/company/arpida" alt="Arpida on Indexed.vc" width="260" height="76" /></a>